 |
|
|
| |
Five-Year Extended Follow-Up of the Observational BICSTaR Cohort: Final Analysis in People With HIV
Receiving Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Routine Clinical Practice
|
| |
| |
0th European AIDS Conference (EACS); October 15-18, 2025; Paris, France
Joss de Wet1,2, Marcel Lee3, Ansgar Rieke4, Laurent Hocqueloux5, Olivier Robineau6, David Thorpe7, Andrea Marongiu7, Johanna Ramroth7,*, Marion Heinzkill8, Benoit Trottier9
|
| |
|
|
|
|
|
